JP MORGAN/PUT/LEIDOS/145/0.1/20.12.24 Share Price

Warrant

DE000JK9F578

Delayed Börse Stuttgart 09:31:46 08/07/2024 BST
1.25 EUR +1.63% Intraday chart for JP MORGAN/PUT/LEIDOS/145/0.1/20.12.24
Current month+2.50%
1 month-3.91%
Date Price Change
08/07/24 1.25 +1.63%
05/07/24 1.23 +3.36%
04/07/24 1.19 -5.56%
03/07/24 1.26 -2.33%
02/07/24 1.29 +4.88%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 09:31 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying LEIDOS HOLDINGS, INC.
Issuer J.P. Morgan
WKN JK9F57
ISINDE000JK9F578
Date issued 09/05/2024
Strike 145 $
Maturity 20/12/2024 (166 Days)
Parity 10 : 1
Emission price 0.86
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.44
Lowest since issue 1.06
Delta-0.42x
Omega 4.350
Premium10x
Gearing10.37x
Moneyness 0.9965
Difference Strike -0.51 $
Difference Strike %-0.35%
Spread 0.09
Spread %6.72%
Theoretical value 1.295
Implied Volatility 40.15 %
Total Loss Probability 47.99 %
Intrinsic value 0.000000
Present value 1.295
Break even 130.97 €
Theta-0.03x
Vega0.04x
Rho-0.02x

Company Profile

Leidos Holdings, Inc. specializes in the provision of engineering, technological and scientific services. Net sales by business segment break down as follows: - defense (56.6%): design, engineering and integration of technological solutions for intelligence, airborne surveillance and reconnaissance, maritime and land-based solutions, electronic warfare systems, and automated sensor, alarm, command and control systems, software development, cyber security solutions and data processing and analysis solutions, IT infrastructure development and integration, etc.; - civil security (23.7%): development and integration of solutions for the protection of goods, data and digital information, solutions and systems for air traffic flow control and flight data management, vehicle and cargo inspection, explosives and radiation detection, computer security, environmental management, nuclear security, complex logistics management, etc.; - health (19.7%): integration of complex systems and technological infrastructures for the management of data, medical information and electronic health records, provision of healthcare services, IT systems lifecycle management, research and development of biopharmaceuticals, etc. Net sales by market are divided between the US Department of Defense and the intelligence community (49.4%), government agencies (37.4%) and commercial customers (13.2%). The United States accounts for 91,4% of net sales.
Sector
-
More about the company

Ratings for Leidos Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Leidos Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
145.5 USD
Average target price
159.5 USD
Spread / Average Target
+9.64%
Consensus